Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00567749 · ClinicalTrials.gov registry record
Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population
A clinical trial, sponsored by Chembio Diagnostic Systems.
- Completed
- Registry status
- 10
- Enrollment target
NCT00567749: Completed study, sponsored by Chembio Diagnostic Systems.
NCT00567749 is a clinical trial that has completed, run by Chembio Diagnostic Systems. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00567749 has completed, sponsored by Chembio Diagnostic Systems.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This study is to establish the clinical sensitivity of the Chembio Diagnostics Systems, Inc. Clearview COMPLETE HIV 1/2 Assay and Clearview HIV 1/2 Stat-Pak Assay (Clearview HIV tests) in pediatric subjects who are between 12 and 17 years of age. A minimum of ten (10) known HIV-positive participants will be tested.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00567749
The ClinicalTrials.gov registry entry for NCT00567749 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Chembio Diagnostic Systems, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00567749 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00567749 about?
NCT00567749 is a clinical study titled "Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population". This study is to establish the clinical sensitivity of the Chembio Diagnostics Systems, Inc. Clearview COMPLETE HIV 1/2 Assay and Clearview HIV 1/2 Stat-Pak Assay (Clearview HIV tests) in pediatric subjects who are between 12 and 17 years of age. A minimum of ten (10) known HIV-positive participants...
What is the current status of trial NCT00567749?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2007-12. Estimated completion is 2008-06.
Who is sponsoring clinical trial NCT00567749?
This trial is sponsored by Chembio Diagnostic Systems, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.